Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2012


To view an abstract, select an author from the vertical list on the left.

2012 Grants - Li

The Mechanisms of Action of Gamma-Secretase Modulators

Yueming Li, Ph.D.
Sloan-Kettering Institute for Cancer Research
New York, New York

2012 Investigator-Initiated Research Grant

Gamma-secretase is an enzyme that plays a key role in Alzheimer's disease. It is part of the biochemical pathway that produces beta-amyloid, a protein fragment that aggregates into amyloid plaques, one of the hallmarks of Alzheimer's disease in the brain. Several drugs have been tested that block gamma-secretase, but they have many side effects because gamma-secretase also modifies other important proteins, including a family of proteins called the Notch family.

Yueming Li, Ph.D., and colleagues have proposed to study how two classes of drugs modulate the activity of gamma-secretase without affecting Notch processing. They will use sophisticated molecular techniques to determine how these drugs bind to gamma-secretase and change its shape. Dr. Li's team will also study how combinations of gamma-secretase modulators can alter the production of different forms of beta-amyloid. These studies will provide valuable insights into the development of better gamma-secretase inhibitors, which could become drug candidates for the treatment of Alzheimer's disease.